Advertisement
U.S. markets open in 54 minutes
  • S&P Futures

    5,307.25
    -1.00 (-0.02%)
     
  • Dow Futures

    40,157.00
    +13.00 (+0.03%)
     
  • Nasdaq Futures

    18,501.50
    -2.25 (-0.01%)
     
  • Russell 2000 Futures

    2,139.30
    +0.90 (+0.04%)
     
  • Crude Oil

    82.57
    +1.22 (+1.50%)
     
  • Gold

    2,232.60
    +19.90 (+0.90%)
     
  • Silver

    24.67
    -0.08 (-0.33%)
     
  • EUR/USD

    1.0793
    -0.0036 (-0.33%)
     
  • 10-Yr Bond

    4.2280
    +0.0320 (+0.76%)
     
  • Vix

    13.01
    +0.23 (+1.80%)
     
  • GBP/USD

    1.2623
    -0.0015 (-0.12%)
     
  • USD/JPY

    151.3370
    +0.0910 (+0.06%)
     
  • Bitcoin USD

    70,353.01
    +125.31 (+0.18%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,950.21
    +18.23 (+0.23%)
     
  • Nikkei 225

    40,168.07
    -594.66 (-1.46%)
     

The Zacks Analyst Blog Highlights: Grocery Outlet, Sprouts Farmers, PLDT, Regeneron and Clorox

For Immediate Release

Chicago, IL – April 1, 2020 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Grocery Outlet Holding Corp. GO, Sprouts Farmers Market Inc. SFM, PLDT Inc. PHI, Regeneron Pharmaceuticals Inc. REGN and The Clorox Co. CLX.

Here are highlights from Tuesday’s Analyst Blog:

5 Top Momentum Stocks for April Amid Coronavirus-Led Turmoil

The last month of the first quarter witnessed U.S. stock markets tumble on concerns of a global economic recession due to the coronavirus pandemic. The outbreak of this deadly virus has been triggering significant volatility in global stock markets for the last six weeks. However, last week (ended Mar 27), Wall Street witnessed one of its best weekly performances in its history. The trend continued in the first trading day of this week.

Momentum Likely to Continue

A handful of stocks have withstood the market mayhem in March, some of them are momentum players. Momentum investing calls for a continuous appraisal of stocks, which ensures that an investor does not pick a beaten-down name and overlook a thriving one. Momentum investors buy high on the anticipation that the stock will only ascend in the short to intermediate term.

The recent stock market upsurge may present an ideal buying opportunity for momentum investors. The market has been so oversold in the past five weeks that even a bad news, except for the worst case scenario, will not deter market participants from buying good stocks at an attractive valuation.

The three major stock indexes — the Dow, the S&P 500 and the Nasdaq Composite — tumbled 23.6%, 21.7% and 20.1%, respectively, from their all-time highs recorded last month. Month to date, these indexes — the Dow, the S&P 500 and the Nasdaq Composite — are down 12.1%, 11.1% and 9.3%, respectively, despite the ongoing rally.

Upward Revision of EPS Estimates - A Crucial Indicator

An upward earnings per share (EPS) estimate revision for 2020 of any stock simply means the market is expecting these companies to do good business this year. However, in the past 30 days most stocks witnessed either negative EPS revisions or remained flat due to coronavirus pandemic.

Meanwhile, a positive EPS estimate revision during the period of historic financial turmoil highlights solid business model and robust growth potential of these companies. Investors can certainly take a look at these stocks currently as these have strong earnings momentum.

Our Top Picks

We have narrowed down our search to five momentum stocks that have moved north in March. All these stock witnessed robust earnings estimate revisions in the last 30 days and have solid growth potential. Each of our picks carry a Zacks Rank #1 (Strong Buy) and a Momentum Score of A or B.  You can see the complete list of today’s Zacks #1 Rank stocks here.

Grocery Outlet Holding Corp.owns and operates a chain of grocery stores primarily in the United States. The company has an expected earnings growth rate of 12.7% for the current year. The Zacks Consensus Estimate for current year earnings has improved by 9.9% over the past 30 days.

Sprouts Farmers Market Inc.operates as a healthy grocery store, provides fresh, natural and organic food products in the United States. The company has an expected earnings growth rate of 4.8% for the current year. The Zacks Consensus Estimate for current earnings year has improved by 4.8% over the past 30 days.

PLDT Inc.operates as a telecommunications company in the Philippines. The company operates in three segments: Wireless, Fixed Line, and Others. The company has an expected earnings growth rate of 14.9% for the current year. The Zacks Consensus Estimate for current year earnings has improved by 10.6% over the past 30 days.

Regeneron Pharmaceuticals Inc.operates as a telecommunications company in the Philippines. The company operates in three segments: Wireless, Fixed Line, and Others. The company has an expected earnings growth rate of 16.2% for the current year. The Zacks Consensus Estimate for current earnings year has improved by 0.2% over the past 30 days.

The Clorox Co. a biopharmaceutical company, discovers, invents, develops, manufactures, and commercializes medicines for treating various medical conditions worldwide. The company has an expected earnings growth rate of 1.6% for the current year. The Zacks Consensus Estimate for current earnings year has improved by 3.7% over the past 30 days.

Zacks Top 10 Stocks for 2020

In addition to the stocks discussed above, would you like to know about our 10 finest buy-and-hold tickers for the entirety of 2020?

Last year's 2019 Zacks Top 10 Stocks portfolio returned gains as high as +102.7%. Now a brand-new portfolio has been handpicked from over 4,000 companies covered by the Zacks Rank. Don’t miss your chance to get in on these long-term buys.

Access Zacks Top 10 Stocks for 2020 today >>

Join us on Facebook: https://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339

support@zacks.com

https://www.zacks.com

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performancefor information about the performance numbers displayed in this press release.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Regeneron Pharmaceuticals, Inc. (REGN) : Free Stock Analysis Report
 
The Clorox Company (CLX) : Free Stock Analysis Report
 
PLDT Inc. (PHI) : Free Stock Analysis Report
 
Sprouts Farmers Market, Inc. (SFM) : Free Stock Analysis Report
 
Grocery Outlet Holding Corp. (GO) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research

Advertisement